Khosla Rachna 4
4 · AMGEN INC · Filed Mar 19, 2025
Insider Transaction Report
Form 4
AMGEN INCAMGN
Khosla Rachna
SVP, Business Development
Transactions
- Tax Payment
Common Stock
2025-03-17$313.71/sh−489$153,404→ 9,340 total
Footnotes (1)
- [F1]These shares include 162 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.